YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Patient 1

Treat With YUTIQ

Presentation Before YUTIQ Treatment

IOP15 mmHg
Anterior chamber findings+2 cell PCIOL
Vitreous cellTrace cell
Fundus exam findingsERM CME
Continue to monitor for IOP elevations and inflammation recurrence.

Imaging Before YUTIQ Treatment